Comparing Articaine and Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction

• Status: Completed
• Trial end date: 2018-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study compares the the efficacy of buccal infiltration of 4% Articaine and 2% Mepivacaine without any palatal injection during extraction of maxillary teeth. One group of patient receives buccal infiltration of Articaine and another group receives buccal infiltration of Mepivacaine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Melaka Manipal Medical College
• Treatments: Carticaine; Epinephrine; Epinephryl borate; Mepivacaine; Racepinephrine

Criteria

Inclusion Criteria:

• Patients aged 18 years and above

• Patients requiring extraction of maxillary teeth which are grossly decayed, grade I mobile, root stumps or indicated for therapeutic extractions.

• Healthy patients ( ASA I ) or patients with mild systemic disease with no functional limitations (ASA II).

• Patients who are not allergic to the drugs used in the study

Exclusion Criteria:

• Patients with periapical infections.

• Patients who are on concurrent treatment with NSAIDs and corticosteroids